BR112012007069B1 - Derivado de fenol, e composição farmacêutica compreendo o mesmo - Google Patents

Info

Publication number

BR112012007069B1

BR112012007069B1 BR112012007069-0A BR112012007069A BR112012007069B1 BR 112012007069 B1 BR112012007069 B1 BR 112012007069B1 BR 112012007069 A BR112012007069 A BR 112012007069A BR 112012007069 B1 BR112012007069 B1 BR 112012007069B1

Authority

BR

Brazil

Prior art keywords

mixture

added

group

solvent

reduced pressure

Prior art date

2009-09-30

Links

• Espacenet
• Global Dossier
• Discuss

• 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 37
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical class OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 title abstract description 9
• 150000001875 compounds Chemical class 0.000 claims abstract description 245
• 150000003839 salts Chemical class 0.000 claims abstract description 28
• 125000000217 alkyl group Chemical group 0.000 claims abstract description 22
• 150000002989 phenols Chemical class 0.000 claims abstract description 19
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 12
• 125000005843 halogen group Chemical group 0.000 claims abstract description 11
• 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 10
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 7
• 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 5
• 239000000203 mixture Substances 0.000 claims description 373
• -1 isopropylsulfanyl group Chemical group 0.000 claims description 118
• 239000000126 substance Substances 0.000 claims description 71
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 27
• 239000000460 chlorine Substances 0.000 claims description 23
• 229910052801 chlorine Inorganic materials 0.000 claims description 9
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
• 229910052731 fluorine Inorganic materials 0.000 claims description 6
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
• 239000004480 active ingredient Substances 0.000 claims description 4
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
• 238000009472 formulation Methods 0.000 claims description 4
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
• HJNASESSRLKUIE-UHFFFAOYSA-N 3-cyclopropyl-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxybenzonitrile Chemical compound OC1=C(C#N)C=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C1C1CC1 HJNASESSRLKUIE-UHFFFAOYSA-N 0.000 claims description 3
• SBCRKZJEEDTVFK-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-methylsulfanylbenzonitrile Chemical compound N#CC1=C(O)C(SC)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 SBCRKZJEEDTVFK-UHFFFAOYSA-N 0.000 claims description 3
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
• 239000000654 additive Substances 0.000 claims description 3
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
• 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims description 3
• 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 3
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
• VOFLAIHEELWYGO-UHFFFAOYSA-N (3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 VOFLAIHEELWYGO-UHFFFAOYSA-N 0.000 claims description 2
• MTHRZZFLSQRKKO-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-(trifluoromethyl)benzonitrile Chemical compound C1=C(C(F)(F)F)C(O)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 MTHRZZFLSQRKKO-UHFFFAOYSA-N 0.000 claims description 2
• HJNFPLCCPXAZSE-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-3-ethylsulfanyl-2-hydroxybenzonitrile Chemical compound N#CC1=C(O)C(SCC)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 HJNFPLCCPXAZSE-UHFFFAOYSA-N 0.000 claims description 2
• 230000000996 additive effect Effects 0.000 claims description 2
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
• 239000011737 fluorine Substances 0.000 claims 2
• JVXASWJRFPUFOH-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-3-ethyl-2-hydroxybenzonitrile Chemical compound N#CC1=C(O)C(CC)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 JVXASWJRFPUFOH-UHFFFAOYSA-N 0.000 claims 1
• 230000003424 uricosuric effect Effects 0.000 abstract description 25
• 239000012453 solvate Substances 0.000 abstract description 14
• 125000004414 alkyl thio group Chemical group 0.000 abstract description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 8
• 229910052757 nitrogen Inorganic materials 0.000 abstract description 8
• 125000003545 alkoxy group Chemical group 0.000 abstract description 7
• 125000000304 alkynyl group Chemical group 0.000 abstract description 6
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract description 6
• 125000001188 haloalkyl group Chemical group 0.000 abstract description 6
• 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract description 4
• 125000004438 haloalkoxy group Chemical group 0.000 abstract description 4
• 125000000623 heterocyclic group Chemical group 0.000 abstract description 4
• 125000003342 alkenyl group Chemical group 0.000 abstract description 3
• 229910052717 sulfur Inorganic materials 0.000 abstract description 3
• 125000004434 sulfur atom Chemical group 0.000 abstract description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 672
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 315
• 239000000243 solution Substances 0.000 description 310
• 238000004821 distillation Methods 0.000 description 303
• 230000002829 reductive effect Effects 0.000 description 299
• 239000002904 solvent Substances 0.000 description 289
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 286
• 238000003786 synthesis reaction Methods 0.000 description 248
• 230000015572 biosynthetic process Effects 0.000 description 246
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 244
• 239000012044 organic layer Substances 0.000 description 184
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 178
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 147
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 136
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 134
• 239000013078 crystal Substances 0.000 description 105
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 104
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 101
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 101
• 238000006243 chemical reaction Methods 0.000 description 98
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 96
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 81
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 80
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 68
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 66
• 238000005160 1H NMR spectroscopy Methods 0.000 description 63
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 59
• LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 59
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
• WOHLSTOWRAOMSG-UHFFFAOYSA-N 2,3-dihydro-1,3-benzothiazole Chemical compound C1=CC=C2SCNC2=C1 WOHLSTOWRAOMSG-UHFFFAOYSA-N 0.000 description 55
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 47
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 46
• TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 45
• 229940116269 uric acid Drugs 0.000 description 45
• 238000010898 silica gel chromatography Methods 0.000 description 43
• 239000011541 reaction mixture Substances 0.000 description 39
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 33
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 31
• LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 31
• VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 description 30
• 201000010099 disease Diseases 0.000 description 30
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 30
• 229940079593 drug Drugs 0.000 description 30
• 239000003814 drug Substances 0.000 description 30
• 210000002700 urine Anatomy 0.000 description 30
• 201000001431 Hyperuricemia Diseases 0.000 description 27
• 239000007787 solid Substances 0.000 description 27
• 238000010533 azeotropic distillation Methods 0.000 description 23
• 229910000027 potassium carbonate Inorganic materials 0.000 description 23
• 239000010410 layer Substances 0.000 description 22
• 239000003960 organic solvent Substances 0.000 description 22
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 22
• 235000019345 sodium thiosulphate Nutrition 0.000 description 22
• 239000000047 product Substances 0.000 description 21
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 20
• 239000002253 acid Substances 0.000 description 20
• JNUQDPXTKWZWFG-UHFFFAOYSA-N 2,3-dihydro-1,3-benzothiazole 1,1-dioxide Chemical compound C1=CC=C2S(=O)(=O)CNC2=C1 JNUQDPXTKWZWFG-UHFFFAOYSA-N 0.000 description 19
• 239000004354 Hydroxyethyl cellulose Substances 0.000 description 19
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 19
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 19
• 238000003756 stirring Methods 0.000 description 19
• 210000004369 blood Anatomy 0.000 description 18
• 239000008280 blood Substances 0.000 description 18
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 18
• VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 16
• GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 16
• 238000000034 method Methods 0.000 description 16
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
• PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 15
• 230000029142 excretion Effects 0.000 description 15
• 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 15
• 201000005569 Gout Diseases 0.000 description 14
• 150000002148 esters Chemical class 0.000 description 14
• HQULYFAKUZDRPB-UHFFFAOYSA-N 6-bromo-2-[4-(trifluoromethoxy)phenoxy]-1,3-benzothiazole Chemical compound BrC1=CC2=C(N=C(S2)OC2=CC=C(C=C2)OC(F)(F)F)C=C1 HQULYFAKUZDRPB-UHFFFAOYSA-N 0.000 description 13
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
• 238000011282 treatment Methods 0.000 description 13
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 11
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 11
• LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Substances IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 11
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 11
• 230000002265 prevention Effects 0.000 description 11
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
• 238000004519 manufacturing process Methods 0.000 description 10
• 210000001519 tissue Anatomy 0.000 description 10
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
• WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
• 241000700159 Rattus Species 0.000 description 9
• 239000012298 atmosphere Substances 0.000 description 9
• 239000002585 base Substances 0.000 description 9
• 239000003795 chemical substances by application Substances 0.000 description 9
• OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 9
• ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 9
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
• 208000024172 Cardiovascular disease Diseases 0.000 description 8
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
• 125000000524 functional group Chemical group 0.000 description 8
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 8
• 230000003647 oxidation Effects 0.000 description 8
• 238000007254 oxidation reaction Methods 0.000 description 8
• 239000000741 silica gel Substances 0.000 description 8
• 229910002027 silica gel Inorganic materials 0.000 description 8
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 8
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 7
• 229920002678 cellulose Polymers 0.000 description 7
• 239000001913 cellulose Substances 0.000 description 7
• 235000010980 cellulose Nutrition 0.000 description 7
• 238000006460 hydrolysis reaction Methods 0.000 description 7
• 229960003511 macrogol Drugs 0.000 description 7
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
• XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 6
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 6
• JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 6
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
• 230000009471 action Effects 0.000 description 6
• WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 6
• 239000001569 carbon dioxide Substances 0.000 description 6
• 229910002092 carbon dioxide Inorganic materials 0.000 description 6
• 239000001768 carboxy methyl cellulose Substances 0.000 description 6
• 229940061627 chloromethyl methyl ether Drugs 0.000 description 6
• 238000001816 cooling Methods 0.000 description 6
• DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
• WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 6
• 238000001914 filtration Methods 0.000 description 6
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 6
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 6
• 239000011777 magnesium Substances 0.000 description 6
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
• SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 5
• GQWMNVOVQZIPJC-UHFFFAOYSA-N 2-(trifluoromethoxy)phenol Chemical compound OC1=CC=CC=C1OC(F)(F)F GQWMNVOVQZIPJC-UHFFFAOYSA-N 0.000 description 5
• NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
• KUCSFDLSLAVLBY-UHFFFAOYSA-N 3-cyano-4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(C#N)=C1 KUCSFDLSLAVLBY-UHFFFAOYSA-N 0.000 description 5
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
• 206010018634 Gouty Arthritis Diseases 0.000 description 5
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
• 206010020772 Hypertension Diseases 0.000 description 5
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
• 229930006000 Sucrose Natural products 0.000 description 5
• 229960002529 benzbromarone Drugs 0.000 description 5
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
• 238000004440 column chromatography Methods 0.000 description 5
• 238000005859 coupling reaction Methods 0.000 description 5
• OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
• 230000007062 hydrolysis Effects 0.000 description 5
• 210000003734 kidney Anatomy 0.000 description 5
• 208000017169 kidney disease Diseases 0.000 description 5
• 229910052749 magnesium Inorganic materials 0.000 description 5
• 229920000609 methyl cellulose Polymers 0.000 description 5
• 239000001923 methylcellulose Substances 0.000 description 5
• 235000010981 methylcellulose Nutrition 0.000 description 5
• 229910052763 palladium Inorganic materials 0.000 description 5
• 239000000651 prodrug Substances 0.000 description 5
• 229940002612 prodrug Drugs 0.000 description 5
• 125000006239 protecting group Chemical group 0.000 description 5
• 239000007858 starting material Substances 0.000 description 5
• 239000005720 sucrose Substances 0.000 description 5
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
• XWIGDNQZKUVSQD-UHFFFAOYSA-N 3,5-dichloro-4-methoxybenzoyl chloride Chemical compound COC1=C(Cl)C=C(C(Cl)=O)C=C1Cl XWIGDNQZKUVSQD-UHFFFAOYSA-N 0.000 description 4
• PZSZFFGGWLDZEL-UHFFFAOYSA-N 3-formyl-4-methoxy-5-(trifluoromethyl)benzoic acid Chemical compound COC1=C(C=O)C=C(C(O)=O)C=C1C(F)(F)F PZSZFFGGWLDZEL-UHFFFAOYSA-N 0.000 description 4
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
• ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 4
• OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
• 229910021585 Nickel(II) bromide Inorganic materials 0.000 description 4
• 229920002472 Starch Polymers 0.000 description 4
• 239000007864 aqueous solution Substances 0.000 description 4
• 229910052786 argon Inorganic materials 0.000 description 4
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
• 239000003054 catalyst Substances 0.000 description 4
• 125000001309 chloro group Chemical group Cl* 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 239000011248 coating agent Substances 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 125000001153 fluoro group Chemical group F* 0.000 description 4
• 235000019253 formic acid Nutrition 0.000 description 4
• 239000007789 gas Substances 0.000 description 4
• 229910052739 hydrogen Inorganic materials 0.000 description 4
• 239000001257 hydrogen Substances 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 229910052740 iodine Inorganic materials 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 230000004060 metabolic process Effects 0.000 description 4
• AHPCEMBOTQXADD-UHFFFAOYSA-N methyl 3-cyano-4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C(C#N)=C1 AHPCEMBOTQXADD-UHFFFAOYSA-N 0.000 description 4
• DXSRZGRDEIGJIE-UHFFFAOYSA-N methyl 4-hydroxy-3-(trifluoromethoxy)benzoate Chemical compound COC(=O)C1=CC=C(O)C(OC(F)(F)F)=C1 DXSRZGRDEIGJIE-UHFFFAOYSA-N 0.000 description 4
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
• IPLJNQFXJUCRNH-UHFFFAOYSA-L nickel(2+);dibromide Chemical compound [Ni+2].[Br-].[Br-] IPLJNQFXJUCRNH-UHFFFAOYSA-L 0.000 description 4
• 150000007523 nucleic acids Chemical group 0.000 description 4
• 102000039446 nucleic acids Human genes 0.000 description 4
• 108020004707 nucleic acids Proteins 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 239000008107 starch Substances 0.000 description 4
• 235000019698 starch Nutrition 0.000 description 4
• ZGLOPBCSGCLGIW-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[3-(1,1-dioxo-1,3-thiazolidine-3-carbonyl)-4-hydroxy-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C(C(F)(F)F)C(O)=C1C(=O)N1CCS(=O)(=O)C1 ZGLOPBCSGCLGIW-UHFFFAOYSA-N 0.000 description 3
• ANFMJSAUPABGCM-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[4-hydroxy-3-(1,3-thiazolidine-3-carbonyl)-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C(C(F)(F)F)C(O)=C1C(=O)N1CCSC1 ANFMJSAUPABGCM-UHFFFAOYSA-N 0.000 description 3
• LCARXXDVYQTVNF-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-(3,5-dichloro-4-methoxyphenyl)methanone Chemical compound C1=C(Cl)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2SC1 LCARXXDVYQTVNF-UHFFFAOYSA-N 0.000 description 3
• BLRHCQQZPGHYFH-UHFFFAOYSA-N 3-cyano-4-methoxy-5-(trifluoromethyl)benzoyl chloride Chemical compound COC1=C(C#N)C=C(C(Cl)=O)C=C1C(F)(F)F BLRHCQQZPGHYFH-UHFFFAOYSA-N 0.000 description 3
• SOSBEOCAXDOYMI-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-(trifluoromethoxy)benzonitrile Chemical compound C1=C(C#N)C(O)=C(OC(F)(F)F)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 SOSBEOCAXDOYMI-UHFFFAOYSA-N 0.000 description 3
• BRRWXKAWWWNKGN-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-(trifluoromethyl)benzonitrile Chemical compound C1=C(C(F)(F)F)C(OC)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2SC1 BRRWXKAWWWNKGN-UHFFFAOYSA-N 0.000 description 3
• LURWLFVABVOKFV-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-chloro-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2SC1 LURWLFVABVOKFV-UHFFFAOYSA-N 0.000 description 3
• RUAOPBPTDQLQIB-UHFFFAOYSA-N 5-(trifluoromethyl)-2,3-dihydro-1,3-benzothiazole Chemical compound FC(F)(F)C1=CC=C2SCNC2=C1 RUAOPBPTDQLQIB-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
• 229920002261 Corn starch Polymers 0.000 description 3
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 3
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
• 206010018429 Glucose tolerance impaired Diseases 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
• 208000008589 Obesity Diseases 0.000 description 3
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
• 208000009911 Urinary Calculi Diseases 0.000 description 3
• RZXBSMVVNURIFG-UHFFFAOYSA-N [3-chloro-4-hydroxy-5-(trifluoromethyl)phenyl]-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(C(F)(F)F)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 RZXBSMVVNURIFG-UHFFFAOYSA-N 0.000 description 3
• 235000011054 acetic acid Nutrition 0.000 description 3
• WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 3
• 230000001154 acute effect Effects 0.000 description 3
• OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 3
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
• AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
• 229940109239 creatinine Drugs 0.000 description 3
• 238000010511 deprotection reaction Methods 0.000 description 3
• 229910052805 deuterium Inorganic materials 0.000 description 3
• 201000005577 familial hyperlipidemia Diseases 0.000 description 3
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 3
• UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 3
• JGRPKGNZXLXHPE-UHFFFAOYSA-N methyl 3-cyano-4-hydroxy-5-iodobenzoate Chemical compound COC(=O)C1=CC(I)=C(O)C(C#N)=C1 JGRPKGNZXLXHPE-UHFFFAOYSA-N 0.000 description 3
• 229910052759 nickel Inorganic materials 0.000 description 3
• 235000020824 obesity Nutrition 0.000 description 3
• 229920000136 polysorbate Polymers 0.000 description 3
• 229950008882 polysorbate Drugs 0.000 description 3
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
• 238000001308 synthesis method Methods 0.000 description 3
• OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
• RHABKZDRQUZXQE-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[4-hydroxy-3-methylsulfonyl-5-(trifluoromethyl)phenyl]methanone Chemical compound FC(F)(F)C1=C(O)C(S(=O)(=O)C)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 RHABKZDRQUZXQE-UHFFFAOYSA-N 0.000 description 2
• LQNDVNGYLFJLGJ-UHFFFAOYSA-N (3,5-dichloro-4-hydroxyphenyl)-(1-oxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)C1 LQNDVNGYLFJLGJ-UHFFFAOYSA-N 0.000 description 2
• OVVZSVBGHASQCL-UHFFFAOYSA-N (3,5-dichloro-4-hydroxyphenyl)-[1,1-dioxo-5-(trifluoromethyl)-2h-1,3-benzothiazol-3-yl]methanone Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1C(=O)N1C2=CC(C(F)(F)F)=CC=C2S(=O)(=O)C1 OVVZSVBGHASQCL-UHFFFAOYSA-N 0.000 description 2
• NSKAUABFSJSUHS-UHFFFAOYSA-N (3,5-dichloro-4-methoxyphenyl)-(1-oxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(Cl)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)C1 NSKAUABFSJSUHS-UHFFFAOYSA-N 0.000 description 2
• GGDJFJSYIAKEMJ-UHFFFAOYSA-N (3-chloro-4-hydroxy-5-methoxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound ClC1=C(O)C(OC)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 GGDJFJSYIAKEMJ-UHFFFAOYSA-N 0.000 description 2
• WTDNIIPBZKOONK-UHFFFAOYSA-N (3-chloro-4-hydroxy-5-methylsulfanylphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound ClC1=C(O)C(SC)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 WTDNIIPBZKOONK-UHFFFAOYSA-N 0.000 description 2
• QIQDHFHVEFFWNN-UHFFFAOYSA-N (3-chloro-4-methoxy-5-methylsulfanylphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(SC)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 QIQDHFHVEFFWNN-UHFFFAOYSA-N 0.000 description 2
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
• SUFHTGIPVZIIFB-UHFFFAOYSA-N 1-(methoxymethoxy)-2-(trifluoromethoxy)benzene Chemical compound COCOC1=CC=CC=C1OC(F)(F)F SUFHTGIPVZIIFB-UHFFFAOYSA-N 0.000 description 2
• KDGCARXCCUSENF-UHFFFAOYSA-N 1-(methoxymethoxy)-2-(trifluoromethyl)benzene Chemical compound COCOC1=CC=CC=C1C(F)(F)F KDGCARXCCUSENF-UHFFFAOYSA-N 0.000 description 2
• VBQTYLDMNWXKBN-UHFFFAOYSA-N 1-[4-(methoxymethoxy)-3-(trifluoromethoxy)phenyl]ethanone Chemical compound COCOC1=CC=C(C(C)=O)C=C1OC(F)(F)F VBQTYLDMNWXKBN-UHFFFAOYSA-N 0.000 description 2
• XMCRQAAIKUGIJL-UHFFFAOYSA-N 1-[4-(methoxymethoxy)-3-(trifluoromethyl)phenyl]ethanone Chemical compound COCOC1=CC=C(C(C)=O)C=C1C(F)(F)F XMCRQAAIKUGIJL-UHFFFAOYSA-N 0.000 description 2
• JTICWSKLOXFPIH-UHFFFAOYSA-N 1-[4-hydroxy-3-(trifluoromethoxy)phenyl]ethanone Chemical compound CC(=O)C1=CC=C(O)C(OC(F)(F)F)=C1 JTICWSKLOXFPIH-UHFFFAOYSA-N 0.000 description 2
• HKRUXZJKSFFSGF-UHFFFAOYSA-N 1-[4-hydroxy-3-(trifluoromethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=C(O)C(C(F)(F)F)=C1 HKRUXZJKSFFSGF-UHFFFAOYSA-N 0.000 description 2
• AVYSBKLBQKXSDK-UHFFFAOYSA-N 1-cyclobutyl-2-(methoxymethoxy)benzene Chemical compound COCOC1=CC=CC=C1C1CCC1 AVYSBKLBQKXSDK-UHFFFAOYSA-N 0.000 description 2
• MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
• ZOQOPXVJANRGJZ-UHFFFAOYSA-N 2-(trifluoromethyl)phenol Chemical compound OC1=CC=CC=C1C(F)(F)F ZOQOPXVJANRGJZ-UHFFFAOYSA-N 0.000 description 2
• TYOCDHCKTWANIR-UHFFFAOYSA-N 2-[2-(trifluoromethyl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC=C1C(F)(F)F TYOCDHCKTWANIR-UHFFFAOYSA-N 0.000 description 2
• QKIITUNJEPEAIC-UHFFFAOYSA-N 2-hydroxy-3-(trifluoromethoxy)benzaldehyde Chemical compound OC1=C(OC(F)(F)F)C=CC=C1C=O QKIITUNJEPEAIC-UHFFFAOYSA-N 0.000 description 2
• ZUNOXMJBNMKYOM-UHFFFAOYSA-N 2-hydroxy-3-(trifluoromethyl)benzaldehyde Chemical compound OC1=C(C=O)C=CC=C1C(F)(F)F ZUNOXMJBNMKYOM-UHFFFAOYSA-N 0.000 description 2
• ONAAASFKZAGAOC-UHFFFAOYSA-N 2-hydroxy-5-(1-oxo-2h-1,3-benzothiazole-3-carbonyl)-3-(trifluoromethyl)benzonitrile Chemical compound C1=C(C(F)(F)F)C(O)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2S(=O)C1 ONAAASFKZAGAOC-UHFFFAOYSA-N 0.000 description 2
• UKIXFVDVIJMPOV-UHFFFAOYSA-N 2-methoxy-5-(1-oxo-2h-1,3-benzothiazole-3-carbonyl)-3-(trifluoromethyl)benzonitrile Chemical compound C1=C(C(F)(F)F)C(OC)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2S(=O)C1 UKIXFVDVIJMPOV-UHFFFAOYSA-N 0.000 description 2
• BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
• WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
• BUFSCXPYWLGFLM-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-(3,5-dichloro-4-hydroxyphenyl)methanone Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2SC1 BUFSCXPYWLGFLM-UHFFFAOYSA-N 0.000 description 2
• HYWPNBXLUSKOEE-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-(3-chloro-5-fluoro-4-methoxyphenyl)methanone Chemical compound C1=C(Cl)C(OC)=C(F)C=C1C(=O)N1C2=CC=CC=C2SC1 HYWPNBXLUSKOEE-UHFFFAOYSA-N 0.000 description 2
• MZBLSJKXXKWQEV-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-(3-chloro-5-iodo-4-methoxyphenyl)methanone Chemical compound C1=C(I)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2SC1 MZBLSJKXXKWQEV-UHFFFAOYSA-N 0.000 description 2
• QAPPCMJSGVSZQW-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-(3-chloro-5-methoxy-4-phenylmethoxyphenyl)methanone Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3SC2)=CC(Cl)=C1OCC1=CC=CC=C1 QAPPCMJSGVSZQW-UHFFFAOYSA-N 0.000 description 2
• KBVOEIUFUFWXOZ-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-[4-methoxy-3-methylsulfanyl-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(F)(F)F)C(OC)=C(SC)C=C1C(=O)N1C2=CC=CC=C2SC1 KBVOEIUFUFWXOZ-UHFFFAOYSA-N 0.000 description 2
• PUFVCDZNKFTDDH-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-[4-phenylmethoxy-3-(trifluoromethyl)phenyl]methanone Chemical compound FC(F)(F)C1=CC(C(=O)N2C3=CC=CC=C3SC2)=CC=C1OCC1=CC=CC=C1 PUFVCDZNKFTDDH-UHFFFAOYSA-N 0.000 description 2
• XSYZTYQXKIXPRC-UHFFFAOYSA-N 3,5-dichloro-4-methoxybenzoic acid Chemical compound COC1=C(Cl)C=C(C(O)=O)C=C1Cl XSYZTYQXKIXPRC-UHFFFAOYSA-N 0.000 description 2
• KQZUCQYQLNPECC-UHFFFAOYSA-N 3,5-difluoro-4-methoxybenzoyl chloride Chemical compound COC1=C(F)C=C(C(Cl)=O)C=C1F KQZUCQYQLNPECC-UHFFFAOYSA-N 0.000 description 2
• ZCQYTBQLYSQZNX-UHFFFAOYSA-N 3-(dimethylcarbamoyl)-4-methoxy-5-(trifluoromethyl)benzoic acid Chemical compound COC1=C(C(=O)N(C)C)C=C(C(O)=O)C=C1C(F)(F)F ZCQYTBQLYSQZNX-UHFFFAOYSA-N 0.000 description 2
• XIYFOZAIYZTGHS-UHFFFAOYSA-N 3-chloro-4-methoxy-5-(trifluoromethoxy)benzoyl chloride Chemical compound COC1=C(Cl)C=C(C(Cl)=O)C=C1OC(F)(F)F XIYFOZAIYZTGHS-UHFFFAOYSA-N 0.000 description 2
• SQXLEOLXPDUWPU-UHFFFAOYSA-N 3-chloro-4-methoxy-5-(trifluoromethyl)benzoyl chloride Chemical compound COC1=C(Cl)C=C(C(Cl)=O)C=C1C(F)(F)F SQXLEOLXPDUWPU-UHFFFAOYSA-N 0.000 description 2
• OCTTYRYINIDHGX-UHFFFAOYSA-N 3-chloro-5-cyano-4-methoxybenzoic acid Chemical compound COC1=C(Cl)C=C(C(O)=O)C=C1C#N OCTTYRYINIDHGX-UHFFFAOYSA-N 0.000 description 2
• MVYOXPAZTHFOGX-UHFFFAOYSA-N 3-chloro-5-fluoro-4-methoxybenzoyl chloride Chemical compound COC1=C(F)C=C(C(Cl)=O)C=C1Cl MVYOXPAZTHFOGX-UHFFFAOYSA-N 0.000 description 2
• BFCXETQQBNMRHL-UHFFFAOYSA-N 3-chloro-5-iodo-4-methoxybenzoic acid Chemical compound COC1=C(Cl)C=C(C(O)=O)C=C1I BFCXETQQBNMRHL-UHFFFAOYSA-N 0.000 description 2
• YEVSJFFYSPZQTK-UHFFFAOYSA-N 3-cyano-4-methoxy-5-(trifluoromethoxy)benzoic acid Chemical compound COC1=C(OC(F)(F)F)C=C(C(O)=O)C=C1C#N YEVSJFFYSPZQTK-UHFFFAOYSA-N 0.000 description 2
• CGCSNZMURICDDH-UHFFFAOYSA-N 3-cyano-4-methoxy-5-(trifluoromethoxy)benzoyl chloride Chemical compound COC1=C(OC(F)(F)F)C=C(C(Cl)=O)C=C1C#N CGCSNZMURICDDH-UHFFFAOYSA-N 0.000 description 2
• WPYYWRQBIAQXSW-UHFFFAOYSA-N 3-cyano-4-methoxy-5-(trifluoromethyl)benzoic acid Chemical compound COC1=C(C#N)C=C(C(O)=O)C=C1C(F)(F)F WPYYWRQBIAQXSW-UHFFFAOYSA-N 0.000 description 2
• OTZHDJMZVQTSBJ-UHFFFAOYSA-N 3-cyano-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1C#N OTZHDJMZVQTSBJ-UHFFFAOYSA-N 0.000 description 2
• QXUHTGUOOMUSAX-UHFFFAOYSA-N 3-cyano-5-cyclobutyl-4-methoxybenzoic acid Chemical compound COC1=C(C#N)C=C(C(O)=O)C=C1C1CCC1 QXUHTGUOOMUSAX-UHFFFAOYSA-N 0.000 description 2
• BXNGVYQKMVYBSY-UHFFFAOYSA-N 3-cyano-5-cyclopropyl-4-methoxybenzoic acid Chemical compound COC1=C(C#N)C=C(C(O)=O)C=C1C1CC1 BXNGVYQKMVYBSY-UHFFFAOYSA-N 0.000 description 2
• ZDWWZZVGUJEAPH-UHFFFAOYSA-N 3-cyano-5-ethyl-4-methoxybenzoic acid Chemical compound CCC1=CC(C(O)=O)=CC(C#N)=C1OC ZDWWZZVGUJEAPH-UHFFFAOYSA-N 0.000 description 2
• DAJKQDRMOCGCFZ-UHFFFAOYSA-N 3-cyano-5-iodo-4-methoxybenzoic acid Chemical compound COC1=C(I)C=C(C(O)=O)C=C1C#N DAJKQDRMOCGCFZ-UHFFFAOYSA-N 0.000 description 2
• QKIHQZJUUZHFEE-UHFFFAOYSA-N 3-cyclobutyl-2-hydroxybenzaldehyde Chemical compound OC1=C(C=O)C=CC=C1C1CCC1 QKIHQZJUUZHFEE-UHFFFAOYSA-N 0.000 description 2
• RBYZVHASJRAUAT-UHFFFAOYSA-N 3-cyclobutyl-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxybenzonitrile Chemical compound OC1=C(C#N)C=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C1C1CCC1 RBYZVHASJRAUAT-UHFFFAOYSA-N 0.000 description 2
• HPJPLPPIWHCFRU-UHFFFAOYSA-N 3-cyclobutyl-5-formyl-4-methoxybenzoic acid Chemical compound COC1=C(C=O)C=C(C(O)=O)C=C1C1CCC1 HPJPLPPIWHCFRU-UHFFFAOYSA-N 0.000 description 2
• NYWCEAZDLXCFHZ-UHFFFAOYSA-N 3-cyclopropyl-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxybenzonitrile Chemical compound COC1=C(C#N)C=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C1C1CC1 NYWCEAZDLXCFHZ-UHFFFAOYSA-N 0.000 description 2
• PMPKPUUWHRGBGK-UHFFFAOYSA-N 3-formyl-4-methoxy-5-(trifluoromethoxy)benzoic acid Chemical compound COC1=C(OC(F)(F)F)C=C(C(O)=O)C=C1C=O PMPKPUUWHRGBGK-UHFFFAOYSA-N 0.000 description 2
• UTUOGXSFPJVMTM-UHFFFAOYSA-N 3-formyl-4-methoxy-5-(trifluoromethyl)benzoyl chloride Chemical compound COC1=C(C=O)C=C(C(Cl)=O)C=C1C(F)(F)F UTUOGXSFPJVMTM-UHFFFAOYSA-N 0.000 description 2
• LKPYLCPNCUGDDW-UHFFFAOYSA-N 3-formyl-4-methoxy-5-propan-2-ylbenzoic acid Chemical compound COC1=C(C=O)C=C(C(O)=O)C=C1C(C)C LKPYLCPNCUGDDW-UHFFFAOYSA-N 0.000 description 2
• MNCAMXFRLJFWOG-UHFFFAOYSA-N 3-methoxy-4-phenylmethoxy-5-(trifluoromethyl)benzoic acid Chemical compound COC1=CC(C(O)=O)=CC(C(F)(F)F)=C1OCC1=CC=CC=C1 MNCAMXFRLJFWOG-UHFFFAOYSA-N 0.000 description 2
• COJKQOBGICCMKI-UHFFFAOYSA-N 3-tert-butyl-5-cyano-4-methoxybenzoic acid Chemical compound COC1=C(C#N)C=C(C(O)=O)C=C1C(C)(C)C COJKQOBGICCMKI-UHFFFAOYSA-N 0.000 description 2
• 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
• ZXCJGZONECYUJG-UHFFFAOYSA-N 4-methoxy-3-methylsulfanyl-5-(trifluoromethyl)benzoic acid Chemical compound COC1=C(SC)C=C(C(O)=O)C=C1C(F)(F)F ZXCJGZONECYUJG-UHFFFAOYSA-N 0.000 description 2
• MDUDZLWMGWNCIQ-UHFFFAOYSA-N 4-phenylmethoxy-3-(trifluoromethyl)benzoic acid Chemical compound FC(F)(F)C1=CC(C(=O)O)=CC=C1OCC1=CC=CC=C1 MDUDZLWMGWNCIQ-UHFFFAOYSA-N 0.000 description 2
• RUAKFNSQCVMBQX-UHFFFAOYSA-N 4-phenylmethoxy-3-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC(C(Cl)=O)=CC=C1OCC1=CC=CC=C1 RUAKFNSQCVMBQX-UHFFFAOYSA-N 0.000 description 2
• LNEDCBOGKQHRHD-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-propan-2-ylbenzonitrile Chemical compound N#CC1=C(O)C(C(C)C)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 LNEDCBOGKQHRHD-UHFFFAOYSA-N 0.000 description 2
• MPRBTYZPQYBZIR-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-n,n-dimethyl-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=C(O)C(C(=O)N(C)C)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 MPRBTYZPQYBZIR-UHFFFAOYSA-N 0.000 description 2
• LVVUXMRKNHFURB-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxybenzonitrile Chemical compound C1=C(C#N)C(O)=CC=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 LVVUXMRKNHFURB-UHFFFAOYSA-N 0.000 description 2
• FDKZNTXERULFDD-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-(trifluoromethoxy)benzonitrile Chemical compound C1=C(C#N)C(OC)=C(OC(F)(F)F)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 FDKZNTXERULFDD-UHFFFAOYSA-N 0.000 description 2
• DDGNGWBLULODLW-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-methylsulfanylbenzonitrile Chemical compound C1=C(C#N)C(OC)=C(SC)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 DDGNGWBLULODLW-UHFFFAOYSA-N 0.000 description 2
• RMEDXXXFCDFCBM-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-n,n-dimethyl-3-(trifluoromethyl)benzamide Chemical compound C1=C(C(F)(F)F)C(OC)=C(C(=O)N(C)C)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 RMEDXXXFCDFCBM-UHFFFAOYSA-N 0.000 description 2
• SPGKGQZLVLIZIW-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=CC=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 SPGKGQZLVLIZIW-UHFFFAOYSA-N 0.000 description 2
• OGCQMWGDTFSQEL-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-3-ethynyl-2-hydroxybenzonitrile Chemical compound C1=C(C#N)C(O)=C(C#C)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 OGCQMWGDTFSQEL-UHFFFAOYSA-N 0.000 description 2
• BODOFMMRZVZKAG-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-(trifluoromethyl)benzaldehyde Chemical compound C1=C(C(F)(F)F)C(OC)=C(C=O)C=C1C(=O)N1C2=CC=CC=C2SC1 BODOFMMRZVZKAG-UHFFFAOYSA-N 0.000 description 2
• ZXVFGIJMHGUSJM-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-propan-2-ylbenzonitrile Chemical compound C1=C(C(C)C)C(OC)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2SC1 ZXVFGIJMHGUSJM-UHFFFAOYSA-N 0.000 description 2
• HCKYAAIIYKUFJW-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-n,n-dimethyl-3-(trifluoromethyl)benzamide Chemical compound C1=C(C(F)(F)F)C(OC)=C(C(=O)N(C)C)C=C1C(=O)N1C2=CC=CC=C2SC1 HCKYAAIIYKUFJW-UHFFFAOYSA-N 0.000 description 2
• SYHVSULTUDUPAW-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=CC=C1C(=O)N1C2=CC=CC=C2SC1 SYHVSULTUDUPAW-UHFFFAOYSA-N 0.000 description 2
• XMYMZSXKWAAQLR-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-cyclobutyl-2-methoxybenzonitrile Chemical compound COC1=C(C#N)C=C(C(=O)N2C3=CC=CC=C3SC2)C=C1C1CCC1 XMYMZSXKWAAQLR-UHFFFAOYSA-N 0.000 description 2
• PQXCCYQFVMAPRQ-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-cyclopropyl-2-methoxybenzonitrile Chemical compound COC1=C(C#N)C=C(C(=O)N2C3=CC=CC=C3SC2)C=C1C1CC1 PQXCCYQFVMAPRQ-UHFFFAOYSA-N 0.000 description 2
• KVAZOGSPPPCOLV-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-ethyl-2-methoxybenzonitrile Chemical compound N#CC1=C(OC)C(CC)=CC(C(=O)N2C3=CC=CC=C3SC2)=C1 KVAZOGSPPPCOLV-UHFFFAOYSA-N 0.000 description 2
• NBZNUYSUOLWETC-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-tert-butyl-2-methoxybenzonitrile Chemical compound C1=C(C(C)(C)C)C(OC)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2SC1 NBZNUYSUOLWETC-UHFFFAOYSA-N 0.000 description 2
• NCOPDQCEVBJGNB-UHFFFAOYSA-N 5-bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde Chemical compound OC1=C(C=O)C=C(Br)C=C1C(F)(F)F NCOPDQCEVBJGNB-UHFFFAOYSA-N 0.000 description 2
• REHUIVZWVDPCHL-UHFFFAOYSA-N 5-bromo-2-hydroxy-3-propan-2-ylbenzaldehyde Chemical compound CC(C)C1=CC(Br)=CC(C=O)=C1O REHUIVZWVDPCHL-UHFFFAOYSA-N 0.000 description 2
• OUAMAMSZFYYEJN-UHFFFAOYSA-N 5-bromo-2-methoxy-3-(trifluoromethoxy)benzaldehyde Chemical compound COC1=C(OC(F)(F)F)C=C(Br)C=C1C=O OUAMAMSZFYYEJN-UHFFFAOYSA-N 0.000 description 2
• GLIBUUMOKPPOAL-UHFFFAOYSA-N 5-bromo-2-methoxy-3-(trifluoromethyl)benzaldehyde Chemical compound COC1=C(C=O)C=C(Br)C=C1C(F)(F)F GLIBUUMOKPPOAL-UHFFFAOYSA-N 0.000 description 2
• UKEFSYFSVMCYHS-UHFFFAOYSA-N 5-bromo-2-methoxy-3-propan-2-ylbenzaldehyde Chemical compound COC1=C(C=O)C=C(Br)C=C1C(C)C UKEFSYFSVMCYHS-UHFFFAOYSA-N 0.000 description 2
• MHFDKHJSQFFMSB-UHFFFAOYSA-N 5-bromo-3-cyclobutyl-2-hydroxybenzaldehyde Chemical compound OC1=C(C=O)C=C(Br)C=C1C1CCC1 MHFDKHJSQFFMSB-UHFFFAOYSA-N 0.000 description 2
• GIBGZOXUWATYPC-UHFFFAOYSA-N 5-bromo-3-cyclobutyl-2-methoxybenzaldehyde Chemical compound COC1=C(C=O)C=C(Br)C=C1C1CCC1 GIBGZOXUWATYPC-UHFFFAOYSA-N 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
• 239000005995 Aluminium silicate Substances 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
• 0 C*C(C=C(C=C)C(N(C*1)c2c1cccc2)=O)=C(C*)O Chemical compound C*C(C=C(C=C)C(N(C*1)c2c1cccc2)=O)=C(C*)O 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 206010007572 Cardiac hypertrophy Diseases 0.000 description 2
• 208000006029 Cardiomegaly Diseases 0.000 description 2
• 208000014882 Carotid artery disease Diseases 0.000 description 2
• 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 206010012289 Dementia Diseases 0.000 description 2
• 239000004375 Dextrin Substances 0.000 description 2
• 229920001353 Dextrin Polymers 0.000 description 2
• CETBSQOFQKLHHZ-UHFFFAOYSA-N Diethyl disulfide Chemical compound CCSSCC CETBSQOFQKLHHZ-UHFFFAOYSA-N 0.000 description 2
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
• 206010048554 Endothelial dysfunction Diseases 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 229920000084 Gum arabic Polymers 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 206010067125 Liver injury Diseases 0.000 description 2
• 208000001145 Metabolic Syndrome Diseases 0.000 description 2
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
• 206010033645 Pancreatitis Diseases 0.000 description 2
• KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 239000004372 Polyvinyl alcohol Substances 0.000 description 2
• 208000001647 Renal Insufficiency Diseases 0.000 description 2
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 108010093894 Xanthine oxidase Proteins 0.000 description 2
• VHHPDZDTKZOHTB-UHFFFAOYSA-M [Br-].[Mg+]C.C1CCOC1 Chemical compound [Br-].[Mg+]C.C1CCOC1 VHHPDZDTKZOHTB-UHFFFAOYSA-M 0.000 description 2
• 210000001015 abdomen Anatomy 0.000 description 2
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
• 235000010489 acacia gum Nutrition 0.000 description 2
• 239000000205 acacia gum Substances 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 229960003459 allopurinol Drugs 0.000 description 2
• 235000012211 aluminium silicate Nutrition 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 230000002421 anti-septic effect Effects 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 229940064004 antiseptic throat preparations Drugs 0.000 description 2
• 229960000686 benzalkonium chloride Drugs 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
• OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229960005069 calcium Drugs 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 230000001914 calming effect Effects 0.000 description 2
• 208000026106 cerebrovascular disease Diseases 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 208000020832 chronic kidney disease Diseases 0.000 description 2
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
• GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
• 239000008120 corn starch Substances 0.000 description 2
• 208000029078 coronary artery disease Diseases 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 231100000517 death Toxicity 0.000 description 2
• 235000019425 dextrin Nutrition 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 201000000523 end stage renal failure Diseases 0.000 description 2
• 230000008694 endothelial dysfunction Effects 0.000 description 2
• 230000032050 esterification Effects 0.000 description 2
• 238000005886 esterification reaction Methods 0.000 description 2
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
• ACSXMIMEVVIEQV-UHFFFAOYSA-N ethyl 3-methoxy-4-phenylmethoxy-5-(trifluoromethyl)benzoate Chemical compound FC(F)(F)C1=CC(C(=O)OCC)=CC(OC)=C1OCC1=CC=CC=C1 ACSXMIMEVVIEQV-UHFFFAOYSA-N 0.000 description 2
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 229940093915 gynecological organic acid Drugs 0.000 description 2
• 230000002140 halogenating effect Effects 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 231100000234 hepatic damage Toxicity 0.000 description 2
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 239000007951 isotonicity adjuster Substances 0.000 description 2
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
• 201000006370 kidney failure Diseases 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 239000007788 liquid Substances 0.000 description 2
• 230000008818 liver damage Effects 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 230000010534 mechanism of action Effects 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• RKUNSPWAQIUGEZ-UHFFFAOYSA-N methyl 3-bromo-4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C(Br)=C1 RKUNSPWAQIUGEZ-UHFFFAOYSA-N 0.000 description 2
• YXUBZDHIBCEIOT-UHFFFAOYSA-N methyl 3-chloro-4-hydroxy-5-(trifluoromethoxy)benzoate Chemical compound COC(=O)C1=CC(Cl)=C(O)C(OC(F)(F)F)=C1 YXUBZDHIBCEIOT-UHFFFAOYSA-N 0.000 description 2
• UZPZGXPEFJCFGZ-UHFFFAOYSA-N methyl 3-chloro-4-methoxy-5-(trifluoromethoxy)benzoate Chemical compound COC(=O)C1=CC(Cl)=C(OC)C(OC(F)(F)F)=C1 UZPZGXPEFJCFGZ-UHFFFAOYSA-N 0.000 description 2
• GQPXYNMBPLSNQT-UHFFFAOYSA-N methyl 3-chloro-5-cyano-4-hydroxybenzoate Chemical compound COC(=O)C1=CC(Cl)=C(O)C(C#N)=C1 GQPXYNMBPLSNQT-UHFFFAOYSA-N 0.000 description 2
• CCRJCQCBZLEJRF-UHFFFAOYSA-N methyl 3-chloro-5-cyano-4-methoxybenzoate Chemical compound COC(=O)C1=CC(Cl)=C(OC)C(C#N)=C1 CCRJCQCBZLEJRF-UHFFFAOYSA-N 0.000 description 2
• HMBJJSNGKRZHRE-UHFFFAOYSA-N methyl 3-cyano-5-iodo-4-methoxybenzoate Chemical compound COC(=O)C1=CC(I)=C(OC)C(C#N)=C1 HMBJJSNGKRZHRE-UHFFFAOYSA-N 0.000 description 2
• XWFLMNVSFQPZMY-UHFFFAOYSA-N methyl 3-tert-butyl-4-hydroxy-5-iodobenzoate Chemical compound COC(=O)C1=CC(I)=C(O)C(C(C)(C)C)=C1 XWFLMNVSFQPZMY-UHFFFAOYSA-N 0.000 description 2
• MTZXJBISRMVKSR-UHFFFAOYSA-N methyl 3-tert-butyl-4-hydroxy-5-methylsulfanylbenzoate Chemical compound COC(=O)C1=CC(SC)=C(O)C(C(C)(C)C)=C1 MTZXJBISRMVKSR-UHFFFAOYSA-N 0.000 description 2
• RRGVVWMIXUBORH-UHFFFAOYSA-N methyl 3-tert-butyl-4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C(C(C)(C)C)=C1 RRGVVWMIXUBORH-UHFFFAOYSA-N 0.000 description 2
• SFFUSWURBINQFY-UHFFFAOYSA-N methyl 3-tert-butyl-4-methoxy-5-methylsulfanylbenzoate Chemical compound COC(=O)C1=CC(SC)=C(OC)C(C(C)(C)C)=C1 SFFUSWURBINQFY-UHFFFAOYSA-N 0.000 description 2
• NHACFJFSHQDQCW-UHFFFAOYSA-N methyl 3-tert-butyl-4-methoxy-5-methylsulfonylbenzoate Chemical compound COC(=O)C1=CC(C(C)(C)C)=C(OC)C(S(C)(=O)=O)=C1 NHACFJFSHQDQCW-UHFFFAOYSA-N 0.000 description 2
• QLERMRRDOCTWGL-UHFFFAOYSA-N methyl 3-tert-butyl-5-iodo-4-methoxybenzoate Chemical compound COC(=O)C1=CC(I)=C(OC)C(C(C)(C)C)=C1 QLERMRRDOCTWGL-UHFFFAOYSA-N 0.000 description 2
• XQCZPIGMGYJION-UHFFFAOYSA-N methyl 4-phenylmethoxy-3-(trifluoromethyl)benzoate Chemical compound FC(F)(F)C1=CC(C(=O)OC)=CC=C1OCC1=CC=CC=C1 XQCZPIGMGYJION-UHFFFAOYSA-N 0.000 description 2
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
• 210000003470 mitochondria Anatomy 0.000 description 2
• 208000010125 myocardial infarction Diseases 0.000 description 2
• DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
• 230000004770 neurodegeneration Effects 0.000 description 2
• 208000015122 neurodegenerative disease Diseases 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 235000005985 organic acids Nutrition 0.000 description 2
• 150000002923 oximes Chemical class 0.000 description 2
• 239000003002 pH adjusting agent Substances 0.000 description 2
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
• 229920002451 polyvinyl alcohol Polymers 0.000 description 2
• 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 238000003825 pressing Methods 0.000 description 2
• 229960003081 probenecid Drugs 0.000 description 2
• DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 2
• 229960005206 pyrazinamide Drugs 0.000 description 2
• IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 2
• 238000001953 recrystallisation Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000006722 reduction reaction Methods 0.000 description 2
• 201000002859 sleep apnea Diseases 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• 239000001509 sodium citrate Substances 0.000 description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
• 239000012312 sodium hydride Substances 0.000 description 2
• 229910000104 sodium hydride Inorganic materials 0.000 description 2
• 159000000000 sodium salts Chemical class 0.000 description 2
• 229910052938 sodium sulfate Inorganic materials 0.000 description 2
• 235000011152 sodium sulphate Nutrition 0.000 description 2
• 239000004334 sorbic acid Substances 0.000 description 2
• 235000010199 sorbic acid Nutrition 0.000 description 2
• 229940075582 sorbic acid Drugs 0.000 description 2
• 229960002920 sorbitol Drugs 0.000 description 2
• PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 238000009495 sugar coating Methods 0.000 description 2
• 150000003457 sulfones Chemical class 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• CGTKGQNJNTTZNS-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[3-methoxy-4-phenylmethoxy-5-(trifluoromethyl)phenyl]methanone Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=CC(C(F)(F)F)=C1OCC1=CC=CC=C1 CGTKGQNJNTTZNS-UHFFFAOYSA-N 0.000 description 1
• JTTVMIIALMAOOF-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[4-hydroxy-3-(1-oxo-1,3-thiazolidine-3-carbonyl)-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C(C(F)(F)F)C(O)=C1C(=O)N1CCS(=O)C1 JTTVMIIALMAOOF-UHFFFAOYSA-N 0.000 description 1
• CORNPDQXKOIHQL-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[4-hydroxy-3-(pyrrolidine-1-carbonyl)-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C(C(F)(F)F)C(O)=C1C(=O)N1CCCC1 CORNPDQXKOIHQL-UHFFFAOYSA-N 0.000 description 1
• WGKHQHFWGVDCBM-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[4-methoxy-3-methylsulfonyl-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(S(C)(=O)=O)C(OC)=C(C(F)(F)F)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 WGKHQHFWGVDCBM-UHFFFAOYSA-N 0.000 description 1
• ZFWNIKWLTWAEMM-UHFFFAOYSA-N (1,1-dioxo-2h-1,3-benzothiazol-3-yl)-[4-phenylmethoxy-3-(trifluoromethyl)phenyl]methanone Chemical compound FC(F)(F)C1=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=CC=C1OCC1=CC=CC=C1 ZFWNIKWLTWAEMM-UHFFFAOYSA-N 0.000 description 1
• FEXBXMFVRKZOOZ-UHFFFAOYSA-N (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-6-hydroxy-1-benzofuran-3-yl)methanone Chemical compound CCC=1OC2=CC(O)=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 FEXBXMFVRKZOOZ-UHFFFAOYSA-N 0.000 description 1
• BOPHLMCKQCZVFY-UHFFFAOYSA-N (3,5-dichloro-4-methoxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(Cl)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 BOPHLMCKQCZVFY-UHFFFAOYSA-N 0.000 description 1
• HSSGHYMUNSPWRN-UHFFFAOYSA-N (3,5-dichloro-4-methoxyphenyl)-[1,1-dioxo-5-(trifluoromethyl)-2h-1,3-benzothiazol-3-yl]methanone Chemical compound C1=C(Cl)C(OC)=C(Cl)C=C1C(=O)N1C2=CC(C(F)(F)F)=CC=C2S(=O)(=O)C1 HSSGHYMUNSPWRN-UHFFFAOYSA-N 0.000 description 1
• XPQSQRYFHLMZKX-UHFFFAOYSA-N (3,5-dichloro-4-methoxyphenyl)-[5-(trifluoromethyl)-2h-1,3-benzothiazol-3-yl]methanone Chemical compound C1=C(Cl)C(OC)=C(Cl)C=C1C(=O)N1C2=CC(C(F)(F)F)=CC=C2SC1 XPQSQRYFHLMZKX-UHFFFAOYSA-N 0.000 description 1
• GFVCDMROEQOVLN-UHFFFAOYSA-N (3,5-difluoro-4-hydroxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(F)C(O)=C(F)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 GFVCDMROEQOVLN-UHFFFAOYSA-N 0.000 description 1
• LDRNXZDCONMUSZ-UHFFFAOYSA-N (3,5-difluoro-4-methoxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(F)C(OC)=C(F)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 LDRNXZDCONMUSZ-UHFFFAOYSA-N 0.000 description 1
• HGIUZZNINRTXPH-UHFFFAOYSA-N (3-chloro-4-hydroxy-5-methylsulfinylphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound ClC1=C(O)C(S(=O)C)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 HGIUZZNINRTXPH-UHFFFAOYSA-N 0.000 description 1
• WALNTACXPQVEPD-UHFFFAOYSA-N (3-chloro-5-methoxy-4-phenylmethoxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=CC(Cl)=C1OCC1=CC=CC=C1 WALNTACXPQVEPD-UHFFFAOYSA-N 0.000 description 1
• XMPKMIRQADRMRE-UHFFFAOYSA-N 1,1-dioxo-2,3-dihydro-1,3-benzothiazol-6-ol Chemical compound OC1=CC=C2NCS(=O)(=O)C2=C1 XMPKMIRQADRMRE-UHFFFAOYSA-N 0.000 description 1
• UDHBJMJETZDHBA-UHFFFAOYSA-N 1,3-benzothiazole 1,1-dioxide Chemical compound C1=CC=C2S(=O)(=O)C=NC2=C1 UDHBJMJETZDHBA-UHFFFAOYSA-N 0.000 description 1
• OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• IONYGGJUUJFXJK-UHFFFAOYSA-N 2,3,4,5,6-pentachlorobenzoic acid Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IONYGGJUUJFXJK-UHFFFAOYSA-N 0.000 description 1
• WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 1
• XUZLFWSITDPGPS-UHFFFAOYSA-N 2-(trifluoromethyl)benzenethiol hydrochloride Chemical compound Cl.FC(F)(F)C1=C(C=CC=C1)S XUZLFWSITDPGPS-UHFFFAOYSA-N 0.000 description 1
• QFLBBLZROQPTAI-UHFFFAOYSA-N 2-[2-(trifluoromethoxy)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC=C1OC(F)(F)F QFLBBLZROQPTAI-UHFFFAOYSA-N 0.000 description 1
• DCAIEYUJOVJWCG-UHFFFAOYSA-N 2-cyclobutylphenol Chemical compound OC1=CC=CC=C1C1CCC1 DCAIEYUJOVJWCG-UHFFFAOYSA-N 0.000 description 1
• ORJQGHNTYRXBJF-UHFFFAOYSA-N 2-hydroxy-3-propan-2-ylbenzaldehyde Chemical compound CC(C)C1=CC=CC(C=O)=C1O ORJQGHNTYRXBJF-UHFFFAOYSA-N 0.000 description 1
• IRZZZCAHDSKVNY-UHFFFAOYSA-N 2-methoxy-3-(trifluoromethyl)-5-[5-(trifluoromethyl)-2h-1,3-benzothiazole-3-carbonyl]benzonitrile Chemical compound C1=C(C(F)(F)F)C(OC)=C(C#N)C=C1C(=O)N1C2=CC(C(F)(F)F)=CC=C2SC1 IRZZZCAHDSKVNY-UHFFFAOYSA-N 0.000 description 1
• COVAZHQHYXQLOT-UHFFFAOYSA-N 2-methoxy-3-(trifluoromethyl)benzoic acid Chemical compound COC1=C(C(O)=O)C=CC=C1C(F)(F)F COVAZHQHYXQLOT-UHFFFAOYSA-N 0.000 description 1
• KCLHJKOZELHWQB-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-(3,5-difluoro-4-methoxyphenyl)methanone Chemical compound C1=C(F)C(OC)=C(F)C=C1C(=O)N1C2=CC=CC=C2SC1 KCLHJKOZELHWQB-UHFFFAOYSA-N 0.000 description 1
• GHFAAUJZZNHTLC-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-[3-chloro-4-methoxy-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(F)(F)F)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2SC1 GHFAAUJZZNHTLC-UHFFFAOYSA-N 0.000 description 1
• JDPZBOUERWNUJY-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-[3-methoxy-4-phenylmethoxy-5-(trifluoromethyl)phenyl]methanone Chemical compound COC1=CC(C(=O)N2C3=CC=CC=C3SC2)=CC(C(F)(F)F)=C1OCC1=CC=CC=C1 JDPZBOUERWNUJY-UHFFFAOYSA-N 0.000 description 1
• AMXRBJAEIHKAAI-UHFFFAOYSA-N 2h-1,3-benzothiazol-3-yl-[4-methoxy-3-(pyrrolidine-1-carbonyl)-5-(trifluoromethyl)phenyl]methanone Chemical compound C1=C(C(=O)N2C3=CC=CC=C3SC2)C=C(C(F)(F)F)C(OC)=C1C(=O)N1CCCC1 AMXRBJAEIHKAAI-UHFFFAOYSA-N 0.000 description 1
• YOWQTTYAQQPSHM-UHFFFAOYSA-N 3,5-difluoro-4-methoxybenzoic acid Chemical compound COC1=C(F)C=C(C(O)=O)C=C1F YOWQTTYAQQPSHM-UHFFFAOYSA-N 0.000 description 1
• TVNUVWLDHOOLRP-UHFFFAOYSA-N 3-(dimethylcarbamoyl)-4-methoxy-5-(trifluoromethyl)benzoyl chloride Chemical compound COC1=C(C(=O)N(C)C)C=C(C(Cl)=O)C=C1C(F)(F)F TVNUVWLDHOOLRP-UHFFFAOYSA-N 0.000 description 1
• AEDQNOLIADXSBB-UHFFFAOYSA-N 3-(dodecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCNCCC(O)=O AEDQNOLIADXSBB-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• YQWWJFARCFMTAE-UHFFFAOYSA-N 3-chloro-4-methoxy-5-(trifluoromethoxy)benzoic acid Chemical compound COC1=C(Cl)C=C(C(O)=O)C=C1OC(F)(F)F YQWWJFARCFMTAE-UHFFFAOYSA-N 0.000 description 1
• JDVPVUPAFTXQDR-UHFFFAOYSA-N 3-chloro-4-methoxy-5-(trifluoromethyl)benzoic acid Chemical compound COC1=C(Cl)C=C(C(O)=O)C=C1C(F)(F)F JDVPVUPAFTXQDR-UHFFFAOYSA-N 0.000 description 1
• QHUSRJSYQNJEFQ-UHFFFAOYSA-N 3-chloro-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxybenzonitrile Chemical compound C1=C(C#N)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 QHUSRJSYQNJEFQ-UHFFFAOYSA-N 0.000 description 1
• KXWRZXQRZARXRD-UHFFFAOYSA-N 3-chloro-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 KXWRZXQRZARXRD-UHFFFAOYSA-N 0.000 description 1
• BGDWCANDPBZYGU-UHFFFAOYSA-N 3-chloro-5-cyano-4-methoxybenzoyl chloride Chemical compound COC1=C(Cl)C=C(C(Cl)=O)C=C1C#N BGDWCANDPBZYGU-UHFFFAOYSA-N 0.000 description 1
• ZPDSIFBJCUZZGA-UHFFFAOYSA-N 3-chloro-5-iodo-4-methoxybenzoyl chloride Chemical compound COC1=C(Cl)C=C(C(Cl)=O)C=C1I ZPDSIFBJCUZZGA-UHFFFAOYSA-N 0.000 description 1
• XKYLFIFHGBXXRC-UHFFFAOYSA-N 3-chloro-5-methoxy-4-phenylmethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(Cl)=C1OCC1=CC=CC=C1 XKYLFIFHGBXXRC-UHFFFAOYSA-N 0.000 description 1
• VPSVUVXKQWGGIR-UHFFFAOYSA-N 3-cyano-4-methoxy-2-methylbenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(C)=C1C#N VPSVUVXKQWGGIR-UHFFFAOYSA-N 0.000 description 1
• BOBWOQRDYNPAOA-UHFFFAOYSA-N 3-cyano-4-methoxy-5-propan-2-ylbenzoic acid Chemical compound COC1=C(C#N)C=C(C(O)=O)C=C1C(C)C BOBWOQRDYNPAOA-UHFFFAOYSA-N 0.000 description 1
• LTNXFBWQQSCIRS-UHFFFAOYSA-N 3-cyano-4-methoxy-5-propan-2-ylbenzoyl chloride Chemical compound COC1=C(C#N)C=C(C(Cl)=O)C=C1C(C)C LTNXFBWQQSCIRS-UHFFFAOYSA-N 0.000 description 1
• KZJFPTMKPSNCDL-UHFFFAOYSA-N 3-cyano-4-methoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1C#N KZJFPTMKPSNCDL-UHFFFAOYSA-N 0.000 description 1
• RERSCYUNVYCBKM-UHFFFAOYSA-N 3-cyano-5-cyclobutyl-4-methoxybenzoyl chloride Chemical compound COC1=C(C#N)C=C(C(Cl)=O)C=C1C1CCC1 RERSCYUNVYCBKM-UHFFFAOYSA-N 0.000 description 1
• RTUWIZLTQHHJND-UHFFFAOYSA-N 3-cyano-5-cyclopropyl-4-methoxybenzoyl chloride Chemical compound COC1=C(C#N)C=C(C(Cl)=O)C=C1C1CC1 RTUWIZLTQHHJND-UHFFFAOYSA-N 0.000 description 1
• RBZNTYFMJNYSOR-UHFFFAOYSA-N 3-cyano-5-ethyl-4-methoxybenzoyl chloride Chemical compound CCC1=CC(C(Cl)=O)=CC(C#N)=C1OC RBZNTYFMJNYSOR-UHFFFAOYSA-N 0.000 description 1
• WHDCFCUXUVABMI-UHFFFAOYSA-N 3-cyano-5-ethynyl-4-methoxybenzoic acid Chemical compound COC1=C(C#C)C=C(C(O)=O)C=C1C#N WHDCFCUXUVABMI-UHFFFAOYSA-N 0.000 description 1
• HUJKHWONUZNFSK-UHFFFAOYSA-N 3-cyano-5-ethynyl-4-methoxybenzoyl chloride Chemical compound COC1=C(C#C)C=C(C(Cl)=O)C=C1C#N HUJKHWONUZNFSK-UHFFFAOYSA-N 0.000 description 1
• QJIYPFGEXUBCLH-UHFFFAOYSA-N 3-cyano-5-iodo-4-methoxybenzoyl chloride Chemical compound COC1=C(I)C=C(C(Cl)=O)C=C1C#N QJIYPFGEXUBCLH-UHFFFAOYSA-N 0.000 description 1
• SYSUIGIUZPLNJL-UHFFFAOYSA-N 3-cyclobutyl-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxybenzonitrile Chemical compound COC1=C(C#N)C=C(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)C=C1C1CCC1 SYSUIGIUZPLNJL-UHFFFAOYSA-N 0.000 description 1
• HRADVHZVMOMEPU-UHFFFAOYSA-N 3-iodopyrrolidine-2,5-dione Chemical compound IC1CC(=O)NC1=O HRADVHZVMOMEPU-UHFFFAOYSA-N 0.000 description 1
• RBIHVOMFOWJHFA-UHFFFAOYSA-N 3-methoxy-4-phenylmethoxy-5-(trifluoromethyl)benzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(C(F)(F)F)=C1OCC1=CC=CC=C1 RBIHVOMFOWJHFA-UHFFFAOYSA-N 0.000 description 1
• RCQRJCBRNBALSJ-UHFFFAOYSA-N 3-tert-butyl-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxybenzonitrile Chemical compound N#CC1=C(O)C(C(C)(C)C)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 RCQRJCBRNBALSJ-UHFFFAOYSA-N 0.000 description 1
• RIONVUNUXGWJLT-UHFFFAOYSA-N 3-tert-butyl-5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxybenzonitrile Chemical compound C1=C(C(C)(C)C)C(OC)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 RIONVUNUXGWJLT-UHFFFAOYSA-N 0.000 description 1
• AHDHYEWSADNFPK-UHFFFAOYSA-N 3-tert-butyl-5-cyano-4-methoxybenzoyl chloride Chemical compound COC1=C(C#N)C=C(C(Cl)=O)C=C1C(C)(C)C AHDHYEWSADNFPK-UHFFFAOYSA-N 0.000 description 1
• NPJVWFOXTYDKOG-UHFFFAOYSA-N 4-(methoxymethoxy)-3-(trifluoromethoxy)benzoic acid Chemical compound COCOc1ccc(cc1OC(F)(F)F)C(O)=O NPJVWFOXTYDKOG-UHFFFAOYSA-N 0.000 description 1
• DPVRVZQEDJVWLS-UHFFFAOYSA-N 4-hydroxy-3-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(O)C(C(F)(F)F)=C1 DPVRVZQEDJVWLS-UHFFFAOYSA-N 0.000 description 1
• FHISZFXGHYDTDW-UHFFFAOYSA-N 4-methoxy-3-(pyrrolidine-1-carbonyl)-5-(trifluoromethyl)benzoic acid Chemical compound C1=C(C(O)=O)C=C(C(F)(F)F)C(OC)=C1C(=O)N1CCCC1 FHISZFXGHYDTDW-UHFFFAOYSA-N 0.000 description 1
• NXHNNNKTNBHMEO-UHFFFAOYSA-N 4-methoxy-3-(pyrrolidine-1-carbonyl)-5-(trifluoromethyl)benzoyl chloride Chemical compound C1=C(C(Cl)=O)C=C(C(F)(F)F)C(OC)=C1C(=O)N1CCCC1 NXHNNNKTNBHMEO-UHFFFAOYSA-N 0.000 description 1
• DTXNPNAIMOWRLM-UHFFFAOYSA-N 4-methoxy-3-methylsulfanyl-5-(trifluoromethyl)benzoyl chloride Chemical compound COC1=C(SC)C=C(C(Cl)=O)C=C1C(F)(F)F DTXNPNAIMOWRLM-UHFFFAOYSA-N 0.000 description 1
• AJMQHWJRSXQFKQ-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-iodobenzonitrile Chemical compound C1=C(C#N)C(O)=C(I)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 AJMQHWJRSXQFKQ-UHFFFAOYSA-N 0.000 description 1
• ZIQZOFGOOVJLLL-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-methylsulfinylbenzonitrile Chemical compound N#CC1=C(O)C(S(=O)C)=CC(C(=O)N2C3=CC=CC=C3S(=O)(=O)C2)=C1 ZIQZOFGOOVJLLL-UHFFFAOYSA-N 0.000 description 1
• LUFQSUGPLCMAED-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-(trifluoromethyl)benzaldehyde Chemical compound C1=C(C(F)(F)F)C(OC)=C(C=O)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 LUFQSUGPLCMAED-UHFFFAOYSA-N 0.000 description 1
• BKUNHBOVWFRQDO-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-(trifluoromethyl)benzoic acid Chemical compound C1=C(C(F)(F)F)C(OC)=C(C(O)=O)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 BKUNHBOVWFRQDO-UHFFFAOYSA-N 0.000 description 1
• KSICOGCYKQTHGE-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-2-methoxy-3-propan-2-ylbenzonitrile Chemical compound C1=C(C(C)C)C(OC)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 KSICOGCYKQTHGE-UHFFFAOYSA-N 0.000 description 1
• KRGXETXQSIKTQR-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-3-ethynyl-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=C(C#C)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 KRGXETXQSIKTQR-UHFFFAOYSA-N 0.000 description 1
• DTVKTCGIPJBLMG-UHFFFAOYSA-N 5-(1,1-dioxo-2h-1,3-benzothiazole-3-carbonyl)-3-iodo-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=C(I)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 DTVKTCGIPJBLMG-UHFFFAOYSA-N 0.000 description 1
• ZMYHQWPKHSCITJ-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-2-hydroxy-3-(trifluoromethyl)benzonitrile Chemical compound C1=C(C(F)(F)F)C(O)=C(C#N)C=C1C(=O)N1C2=CC=CC=C2SC1 ZMYHQWPKHSCITJ-UHFFFAOYSA-N 0.000 description 1
• OLZDNFFYLSXSMQ-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-ethynyl-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=C(C#C)C=C1C(=O)N1C2=CC=CC=C2SC1 OLZDNFFYLSXSMQ-UHFFFAOYSA-N 0.000 description 1
• CZKNVRBUVLQTID-UHFFFAOYSA-N 5-(2h-1,3-benzothiazole-3-carbonyl)-3-iodo-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=C(I)C=C1C(=O)N1C2=CC=CC=C2SC1 CZKNVRBUVLQTID-UHFFFAOYSA-N 0.000 description 1
• FXZUAQHXJOLEJG-UHFFFAOYSA-N 5-bromo-2-hydroxy-3-(trifluoromethoxy)benzaldehyde Chemical compound OC1=C(OC(F)(F)F)C=C(Br)C=C1C=O FXZUAQHXJOLEJG-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 206010001580 Albuminuria Diseases 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 206010002383 Angina Pectoris Diseases 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 108010011485 Aspartame Proteins 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 208000037157 Azotemia Diseases 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• YHUHRZWDQZEMFR-UHFFFAOYSA-N Cc1c(C)c(C=O)cc(C(O)=O)c1 Chemical compound Cc1c(C)c(C=O)cc(C(O)=O)c1 YHUHRZWDQZEMFR-UHFFFAOYSA-N 0.000 description 1
• 101150065749 Churc1 gene Proteins 0.000 description 1
• 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
• AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
• 239000004287 Dehydroacetic acid Substances 0.000 description 1
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
• 208000032928 Dyslipidaemia Diseases 0.000 description 1
• 244000239659 Eucalyptus pulverulenta Species 0.000 description 1
• 238000005618 Fries rearrangement reaction Methods 0.000 description 1
• 208000018522 Gastrointestinal disease Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000007818 Grignard reagent Substances 0.000 description 1
• 101000821903 Homo sapiens Solute carrier family 22 member 12 Proteins 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 239000004166 Lanolin Substances 0.000 description 1
• 229920002884 Laureth 4 Polymers 0.000 description 1
• 208000017170 Lipid metabolism disease Diseases 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 235000019759 Maize starch Nutrition 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 206010053961 Mitochondrial toxicity Diseases 0.000 description 1
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 229930040373 Paraformaldehyde Natural products 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 229920002675 Polyoxyl Polymers 0.000 description 1
• 239000004373 Pullulan Substances 0.000 description 1
• 229920001218 Pullulan Polymers 0.000 description 1
• 102100030935 Solute carrier family 2, facilitated glucose transporter member 9 Human genes 0.000 description 1
• 102100021495 Solute carrier family 22 member 12 Human genes 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
• XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
• 201000004810 Vascular dementia Diseases 0.000 description 1
• 102000005773 Xanthine dehydrogenase Human genes 0.000 description 1
• 108010091383 Xanthine dehydrogenase Proteins 0.000 description 1
• 102100033220 Xanthine oxidase Human genes 0.000 description 1
• FIAGYDIJZOWVAB-UHFFFAOYSA-N [2-sulfanyl-5-(trifluoromethyl)phenyl]azanium;chloride Chemical compound Cl.NC1=CC(C(F)(F)F)=CC=C1S FIAGYDIJZOWVAB-UHFFFAOYSA-N 0.000 description 1
• BQHMPXZQFCMPSM-UHFFFAOYSA-N [3-chloro-4-methoxy-5-(trifluoromethoxy)phenyl]-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(OC(F)(F)F)C(OC)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 BQHMPXZQFCMPSM-UHFFFAOYSA-N 0.000 description 1
• UZADUQHNWBREGQ-UHFFFAOYSA-N [Li]C(C)CC.C1CCCCC1 Chemical compound [Li]C(C)CC.C1CCCCC1 UZADUQHNWBREGQ-UHFFFAOYSA-N 0.000 description 1
• JLCHNBRGUPQWKF-UHFFFAOYSA-J [OH-].[C+4].[OH-].[OH-].[OH-] Chemical compound [OH-].[C+4].[OH-].[OH-].[OH-] JLCHNBRGUPQWKF-UHFFFAOYSA-J 0.000 description 1
• VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
• MOQOOKGPCBQMCY-UHFFFAOYSA-N acetic acid;hexane Chemical compound CC(O)=O.CCCCCC MOQOOKGPCBQMCY-UHFFFAOYSA-N 0.000 description 1
• 230000000397 acetylating effect Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 150000001344 alkene derivatives Chemical class 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
• 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
• 229940024548 aluminum oxide Drugs 0.000 description 1
• 229940063655 aluminum stearate Drugs 0.000 description 1
• SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 230000000202 analgesic effect Effects 0.000 description 1
• 230000003276 anti-hypertensive effect Effects 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 230000002365 anti-tubercular Effects 0.000 description 1
• 239000003524 antilipemic agent Substances 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 229940041181 antineoplastic drug Drugs 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 150000001491 aromatic compounds Chemical class 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
• 239000000605 aspartame Substances 0.000 description 1
• 229960003438 aspartame Drugs 0.000 description 1
• 235000010357 aspartame Nutrition 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 235000019445 benzyl alcohol Nutrition 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 235000013734 beta-carotene Nutrition 0.000 description 1
• 239000011648 beta-carotene Substances 0.000 description 1
• TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
• 229960002747 betacarotene Drugs 0.000 description 1
• 239000012267 brine Substances 0.000 description 1
• 230000031709 bromination Effects 0.000 description 1
• 238000005893 bromination reaction Methods 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
• 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
• FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 229950008138 carmellose Drugs 0.000 description 1
• 230000001925 catabolic effect Effects 0.000 description 1
• 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
• 238000010531 catalytic reduction reaction Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• DAVKOMBJLJVVLC-UHFFFAOYSA-N chloroform;hydrobromide Chemical compound Br.ClC(Cl)Cl DAVKOMBJLJVVLC-UHFFFAOYSA-N 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 239000007979 citrate buffer Substances 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 229960000913 crospovidone Drugs 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• WLVKDFJTYKELLQ-UHFFFAOYSA-N cyclopropylboronic acid Chemical compound OB(O)C1CC1 WLVKDFJTYKELLQ-UHFFFAOYSA-N 0.000 description 1
• 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000000354 decomposition reaction Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 235000019258 dehydroacetic acid Nutrition 0.000 description 1
• 229940061632 dehydroacetic acid Drugs 0.000 description 1
• JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
• PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
• 235000019700 dicalcium phosphate Nutrition 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 210000002249 digestive system Anatomy 0.000 description 1
• 150000004683 dihydrates Chemical class 0.000 description 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
• IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 239000002934 diuretic Substances 0.000 description 1
• 230000001882 diuretic effect Effects 0.000 description 1
• 238000000132 electrospray ionisation Methods 0.000 description 1
• 208000028208 end stage renal disease Diseases 0.000 description 1
• 238000010931 ester hydrolysis Methods 0.000 description 1
• 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
• SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
• UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
• 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 239000000706 filtrate Substances 0.000 description 1
• 239000000989 food dye Substances 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 210000004211 gastric acid Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 150000004795 grignard reagents Chemical class 0.000 description 1
• 238000005911 haloform reaction Methods 0.000 description 1
• KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 235000011167 hydrochloric acid Nutrition 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
• 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
• ATQYNBNTEXNNIK-UHFFFAOYSA-N imidazol-2-ylidene Chemical group [C]1NC=CN1 ATQYNBNTEXNNIK-UHFFFAOYSA-N 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940124589 immunosuppressive drug Drugs 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 201000006334 interstitial nephritis Diseases 0.000 description 1
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
• 238000000752 ionisation method Methods 0.000 description 1
• 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
• 229960000829 kaolin Drugs 0.000 description 1
• 230000003907 kidney function Effects 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 229940039717 lanolin Drugs 0.000 description 1
• 235000019388 lanolin Nutrition 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 239000004973 liquid crystal related substance Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
• NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 229960003194 meglumine Drugs 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
• HQVMBKJRAJYZQK-UHFFFAOYSA-N methyl 2-iodo-3-methylbenzoate Chemical compound COC(=O)C1=CC=CC(C)=C1I HQVMBKJRAJYZQK-UHFFFAOYSA-N 0.000 description 1
• LWVTVKZYDQJCRH-UHFFFAOYSA-N methyl 3-(dimethylcarbamoyl)-4-methoxy-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(C(=O)N(C)C)=C(OC)C(C(F)(F)F)=C1 LWVTVKZYDQJCRH-UHFFFAOYSA-N 0.000 description 1
• SDDUZDVLVLIBHO-UHFFFAOYSA-N methyl 3-chloro-4-hydroxy-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(Cl)=C(O)C(C(F)(F)F)=C1 SDDUZDVLVLIBHO-UHFFFAOYSA-N 0.000 description 1
• YMGQPFUVBBSGQQ-UHFFFAOYSA-N methyl 3-chloro-4-hydroxy-5-iodobenzoate Chemical compound COC(=O)C1=CC(Cl)=C(O)C(I)=C1 YMGQPFUVBBSGQQ-UHFFFAOYSA-N 0.000 description 1
• ZSBIMTDWIGWJPW-UHFFFAOYSA-N methyl 3-chloro-4-hydroxybenzoate Chemical compound COC(=O)C1=CC=C(O)C(Cl)=C1 ZSBIMTDWIGWJPW-UHFFFAOYSA-N 0.000 description 1
• HNJRMYSVHQEJSE-UHFFFAOYSA-N methyl 3-chloro-4-methoxy-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(Cl)=C(OC)C(C(F)(F)F)=C1 HNJRMYSVHQEJSE-UHFFFAOYSA-N 0.000 description 1
• SHHLWRDTDVUNTO-UHFFFAOYSA-N methyl 3-chloro-5-iodo-4-methoxybenzoate Chemical compound COC(=O)C1=CC(Cl)=C(OC)C(I)=C1 SHHLWRDTDVUNTO-UHFFFAOYSA-N 0.000 description 1
• HUABUVYQBJTGPC-UHFFFAOYSA-N methyl 3-cyano-4-methoxy-5-(2-trimethylsilylethynyl)benzoate Chemical compound COC(=O)C1=CC(C#N)=C(OC)C(C#C[Si](C)(C)C)=C1 HUABUVYQBJTGPC-UHFFFAOYSA-N 0.000 description 1
• RYJSFYBJYKFNCF-UHFFFAOYSA-N methyl 3-cyano-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(C#N)=C1 RYJSFYBJYKFNCF-UHFFFAOYSA-N 0.000 description 1
• BVKBVUVLWOBKTC-UHFFFAOYSA-N methyl 3-cyano-5-ethyl-4-methoxybenzoate Chemical compound CCC1=CC(C(=O)OC)=CC(C#N)=C1OC BVKBVUVLWOBKTC-UHFFFAOYSA-N 0.000 description 1
• PJNJNWNJCOEUCT-UHFFFAOYSA-N methyl 3-cyano-5-ethynyl-4-methoxybenzoate Chemical compound COC(=O)C1=CC(C#C)=C(OC)C(C#N)=C1 PJNJNWNJCOEUCT-UHFFFAOYSA-N 0.000 description 1
• CYMZCRYPDSUUQL-UHFFFAOYSA-N methyl 3-formyl-4-methoxy-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(C=O)=C(OC)C(C(F)(F)F)=C1 CYMZCRYPDSUUQL-UHFFFAOYSA-N 0.000 description 1
• OVFCUUADSMXWLC-UHFFFAOYSA-N methyl 3-tert-butyl-5-cyano-4-methoxybenzoate Chemical compound COC(=O)C1=CC(C#N)=C(OC)C(C(C)(C)C)=C1 OVFCUUADSMXWLC-UHFFFAOYSA-N 0.000 description 1
• NTUFFWBNSKQBSA-UHFFFAOYSA-N methyl 4-(methoxymethoxy)-3-(trifluoromethoxy)benzoate Chemical compound COCOC1=CC=C(C(=O)OC)C=C1OC(F)(F)F NTUFFWBNSKQBSA-UHFFFAOYSA-N 0.000 description 1
• WIXKYCQCCJXQPN-UHFFFAOYSA-N methyl 4-hydroxy-3-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC=C(O)C(C(F)(F)F)=C1 WIXKYCQCCJXQPN-UHFFFAOYSA-N 0.000 description 1
• VBOIOOOUEQOTQI-UHFFFAOYSA-N methyl 4-hydroxy-3-iodo-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(I)=C(O)C(C(F)(F)F)=C1 VBOIOOOUEQOTQI-UHFFFAOYSA-N 0.000 description 1
• WRCVNYPTOJJJCE-UHFFFAOYSA-N methyl 4-hydroxy-3-methylsulfanyl-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(SC)=C(O)C(C(F)(F)F)=C1 WRCVNYPTOJJJCE-UHFFFAOYSA-N 0.000 description 1
• CUTCLWDPHGRROM-UHFFFAOYSA-N methyl 4-methoxy-3-methylsulfanyl-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(SC)=C(OC)C(C(F)(F)F)=C1 CUTCLWDPHGRROM-UHFFFAOYSA-N 0.000 description 1
• 150000004702 methyl esters Chemical class 0.000 description 1
• DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
• 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 210000001700 mitochondrial membrane Anatomy 0.000 description 1
• 230000008811 mitochondrial respiratory chain Effects 0.000 description 1
• 231100000296 mitochondrial toxicity Toxicity 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
• 235000019691 monocalcium phosphate Nutrition 0.000 description 1
• 150000004682 monohydrates Chemical class 0.000 description 1
• JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
• 125000006606 n-butoxy group Chemical group 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• 125000003935 n-pentoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
• 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 150000002823 nitrates Chemical class 0.000 description 1
• 150000002829 nitrogen Chemical class 0.000 description 1
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
• 238000012261 overproduction Methods 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
• PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 229920002866 paraformaldehyde Polymers 0.000 description 1
• 150000002978 peroxides Chemical class 0.000 description 1
• 238000011458 pharmacological treatment Methods 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
• FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
• 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
• TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
• 159000000001 potassium salts Chemical class 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
• 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
• 235000018102 proteins Nutrition 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 235000019423 pullulan Nutrition 0.000 description 1
• 239000008213 purified water Substances 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 230000009103 reabsorption Effects 0.000 description 1
• 239000003642 reactive oxygen metabolite Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 235000019192 riboflavin Nutrition 0.000 description 1
• 239000002151 riboflavin Substances 0.000 description 1
• 229960002477 riboflavin Drugs 0.000 description 1
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
• 235000012239 silicon dioxide Nutrition 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
• 229960002218 sodium chlorite Drugs 0.000 description 1
• YFGAFXCSLUUJRG-WCCKRBBISA-M sodium;(2s)-2-amino-5-(diaminomethylideneamino)pentanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCCN=C(N)N YFGAFXCSLUUJRG-WCCKRBBISA-M 0.000 description 1
• SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
• 229940032094 squalane Drugs 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 229960004793 sucrose Drugs 0.000 description 1
• 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
• 150000003462 sulfoxides Chemical class 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 150000003892 tartrate salts Chemical class 0.000 description 1
• 229960003080 taurine Drugs 0.000 description 1
• RKSOPLXZQNSWAS-UHFFFAOYSA-N tert-butyl bromide Chemical compound CC(C)(C)Br RKSOPLXZQNSWAS-UHFFFAOYSA-N 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• 229960005196 titanium dioxide Drugs 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
• CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
• 108010078530 urate transporter Proteins 0.000 description 1
• 208000009852 uremia Diseases 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 239000008215 water for injection Substances 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 238000005550 wet granulation Methods 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1
• XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
• 229940057977 zinc stearate Drugs 0.000 description 1